Virpax Pharmaceuticals In... (VRPX)
NASDAQ: VRPX
· Real-Time Price · USD
0.24
0.00 (0.76%)
At close: May 12, 2025, 12:38 PM
0.76% (1D)
| Bid | 0.24 |
| Market Cap | 304.41K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -12.07M |
| EPS (ttm) | -71 |
| PE Ratio (ttm) | n/a |
| Forward PE | -0.02 |
| Analyst | n/a |
| Ask | 0.28 |
| Volume | 2,615 |
| Avg. Volume (20D) | 407,528 |
| Open | 0.24 |
| Previous Close | 0.24 |
| Day's Range | 0.24 - 0.24 |
| 52-Week Range | 0.14 - 84.75 |
| Beta | 1.53 |
About VRPX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VRPX
Website n/a
1 month ago
-16%
Virpax Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
1 month ago
-23.17%
Virpax Pharmaceuticals shares are trading higher after the company announced positive results from a beagle dog dose range-finding study.
2 months ago · businesswire.com
Virpax's NES100 to be Presented at The Society of Toxicology by NCATSBERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic s...
